Navigation Links
Plant protection research targets cacao in developing countries
Date:5/17/2010

A research collaboration lead by a professor from the Virginia Bioinformatics Institute (VBI) at Virginia Tech will work to develop methods to protect agriculturally important crops in developing countries from devastating attacks from plant pathogens with the support of a $1.45 million award from the BREAD (Basic Research to Enable Agricultural Development) program sponsored by the National Science Foundation (NSF) and the Bill & Melinda Gates Foundation (BMGF).

VBI and Virginia Tech Plant Pathology, Physiology and Weed Science Professor Brett Tyler (https://www.vbi.vt.edu/faculty/personal_pages/brett_tyler), along with Mark Guiltinan (http://guiltinanlab.cas.psu.edu/), Penn State professor of Horticulture, and Shunyuan Xiao (http://carb.umbi.umd.edu/xiaogroup/), associate professor at the University of Maryland, College Park, will develop new approaches for crop protection against a broad range of diseases caused by fungal and fungal-like pathogens. The team's research will target cacao, an economically and ecologically important crop for a number of developing countries, in collaboration with cacao expert Brian Bailey from the U. S. Department of Agriculture's (USDA) Agriculture Research Service (ARS) in Beltsville, Md.

According to the International Cocoa Organization (ICCO), approximately three million tons of cocoa, which is the primary ingredient in chocolate made from cacao seeds, is produced globally each year. Africa produces 70 percent of the world's cocoa and it serves as a major export commodity for many other countries such as Ecuador, Venezuela, Brazil, Costa Rica, Malaysia, and Indonesia. In addition to being an important economic crop for these areas, it also provides many ecological benefits such as rain forest preservation. Plant disease caused by fungal and water mold (oomycete) pathogens place critical limitations on cacao production worldwide. While significant advances have been made in research involving disease resistance for staple food crops such as rice, wheat, and corn, more work is needed involving other crops to help provide food and income options for smallholder farmers in developing countries. Cocoa is predominantly a smallholder crop, with more than 90 percent of the world's production originating from small farms.

The project (http://www.nsf.gov/awardsearch/showAward.do?AwardNumber=0965353) targets two mechanisms that appear to be crucial for the way these pathogens attack plants. One approach will explore the usefulness of an anti-microbial protein to target and impair infection within the feeding parts (haustoria) of the pathogen. A second approach involves blocking the entry of virulence proteins that pathogens secrete into host cells to bring about disease. The most promising strategies will be transferred to cacao and evaluated for their ability to protect against disease.

"To help ensure smallholder communities in developing countries are provided with the kinds of nutrition and income options needed for a healthy life, it is critical that crop improvement strategies be applied to many different kinds of crops," Tyler explains. "One of the strengths of this project is that the tested approaches will potentially be applicable to a wide variety of crop species and diseases that are important to the developing world."


'/>"/>

Contact: Susan Bland
subland@vbi.vt.edu
540-231-7912
Virginia Tech
Source:Eurekalert

Related biology news :

1. Emergence of fungal plant diseases linked to ecological speciation
2. Transplanted adult stem cells provide lasting help to injured hearts
3. Linnaeus 2.0: First E-publication of new plant species
4. Health benefits of wheat can be improved by plant breeding
5. DNA barcoding exposes fake ferns in international plant trade
6. Mays Cold Spring Harbor Protocols features plant gene expression methods, Xenopus imaging
7. CO2 effects on plants increases global warming
8. Lung cancer risk particularly high for heart and liver transplant recipients
9. Study gives green light to plants role in global warming
10. Study gives green light to plants’ role in global warming
11. 20 years of PGD (pre-implantation genetic diagnosis)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: